The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

For four decades, researchers around the world have been trying to develop a vaccine for HIV without any luck. Recently, though, there has been some good news. Linda-Gail Bekker directs the Desmond ...

A supercharged vaccine that remains in the lymph nodes for weeks is likelier to generate more antibody variations, strengthening the immune response. A team at MIT and the Scripps Research Institute ...

Vaccine development remains central to reducing incident HIV globally, particularly where long-acting PrEP access is limited, with therapeutic and preventive approaches advancing in parallel.

When SARS-CoV-2, the coronavirus that causes COVID-19, began spreading worldwide in 2020, many research teams immediately set to work developing a vaccine against it. Building on decades of previous ...

Machine learning reveals unique COVID vaccine immune signatures in people living with HIV, with differences in antibodies, cytokines, and T cell responses.